MMI works with its partner institutions, and collaborators in academia and industry, to develop and deliver clinical and translational research programmes. We are actively involved in project management and coordination of the following programmes:
The Irish Prostate Cancer Outcomes Research (IPCOR) Project is a clinically-led study that aims to improve the treatment and care of men diagnosed with prostate cancer in Ireland thus maximising their quality of life.
The aim of the Irish PROgramme for Stratified ProstatE Cancer Therapy (iPROSPECT) is to develop and implement informed patient stratification and deliver a programme of stratified oncology for patients with prostate cancer.
MMI Research Consortia and Networks
Molecular Medicine Ireland aims to promote a strong multi-disciplinary and cross-institutional collaborative research environment. As such, we are facilitating a central information point that presents an overview of clinical and translational research consortia involving our partner institutions. Here, these research consortia take the opportunity to present a succinct view of their aims and collaborative strengths.
Prostate cancer (PCRC)
The Prostate Cancer Research Consortium is a multi-disciplinary, trans-institutional collaboration bringing together researchers from UCD, TCD, RCSI and DCU along with five teaching hospitals in a combined effort to identify novel disease biomarkers for earlier detection and more reliable prognosis for prostate cancer.